Berberine Molecular Recognition of the Parallel MYC G‑Quadruplex in Solution
journal contributionposted on 22.10.2021, 17:39 authored by Jonathan Dickerhoff, Nicole Brundridge, Scott A. McLuckey, Danzhou Yang
The medicinal natural product berberine is one of the most actively studied and pursued G-quadruplex (G4)-ligands. The major G-quadruplex formed in the promoter region of the MYC oncogene (MycG4) is an attractive drug target and a prominent example and model structure for parallel G-quadruplexes. G4-targeted berberine derivatives have been actively developed; however, the analogue design was based on a previous crystal structure in which berberine binds as a dimer to a parallel G-quadruplex. Herein, we show that in solution, the binding mode and stoichiometry of berberine are substantially different from the crystal structure: berberine binds as a monomer to MycG4 using a base-recruitment mechanism with a reversed orientation in that the positively charged convex side is actually positioned above the tetrad center. Our structure provides a physiologically relevant basis for the future structure-based rational design of G4-targeted berberine derivatives, and this study demonstrates that it is crucial to validate the ligand–DNA interactions.
Read the peer-reviewed publication
physiologically relevant basisattractive drug targettargeted berberine derivativesberberine molecular recognitiong4 )- ligandsprevious crystal structurebased rational designcrystal structureanalogue designberberine bindsstructure providesmodel structurefuture structuretetrad centersubstantially differentstudy demonstratesreversed orientationrecruitment mechanismpursued gpromoter regionprominent exampleparallel gmyc oncogenemajor gbinding modeactually positionedactively studiedactively developed